Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 23, Number 29, 2017

Articles

Free Content Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors
pp. 4207-4208(2)
Authors: Huang, Zunnan; Lee, Mee-Hyun

Favourites:
ADD

Review article

Protein Kinases as Tumor Biomarkers and Therapeutic Targets
pp. 4209-4225(17)
Authors: Quan, Chuntao; Xiao, Juanjuan; Liu, Lin; Duan, Qiuhong; Yuan, Ping; Zhu, Feng

Favourites:
ADD

Protein Tyrosine Signaling and its Potential Therapeutic Implications in Carcinogenesis
pp. 4226-4246(21)
Authors: Kim, Mihwa; Baek, Minwoo; Kim, Dae J.

Favourites:
ADD

Molecular Targeting of ERKs/RSK2 Signaling in Cancers
pp. 4247-4258(12)
Author: Cho, Yong-Yeon

Favourites:
ADD

Role of Protein Kinases and Their Inhibitors in Radiation Response of Tumor Cells
pp. 4259-4280(22)
Authors: Kim, Byeong M.; Yoon, Wonsuck; Shim, Jung-Hyun; Jung, Haiyoung; Lim, Ji H.; Choi, Hyun-Jung; Seo, MiRan; Lee, Tae H.; Min, Sang-Hyun

Favourites:
ADD

Protein Kinases as Targets for Opisthorchis viverrini- Associated Cholangiocarcinoma Therapy
pp. 4281-4289(9)
Authors: Loilome, Watcharin; Dokduang, Hasaya

Favourites:
ADD

Open Access Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
pp. 4303-4310(8)
Authors: Ling, Yuan; Zhang, Zikang; Zhang, Hua; Huang, Zunnan

Favourites:
ADD

Induction of Synthetic Lethality by Natural Compounds Targeting Cancer Signaling
pp. 4311-4320(10)
Authors: Farrand, Lee; Byun, Sanguine

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Application of Kinase Inhibitors for Anti-aging Intervention
pp. 4351-4368(18)
Authors: Cano, Mercedes; Ayala, Antonio; Marotta, Francesco; Arguelles, Sandro

Favourites:
ADD

Protein Kinase Inhibitors as Potential Antimicrobial Drugs Against Tuberculosis, Malaria and HIV
pp. 4369-4389(21)
Authors: Cheng, Yong; Schorey, Jeffrey S.; Zhang, Cheng-Cai; Tan, Xuejuan

Favourites:
ADD

Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design
pp. 4390-4409(20)
Authors: Cong, Xiaojing; Topin, Jeremie; Golebiowski, Jerome

Favourites:
ADD

Targeting CD147 is a Novel Strategy for Antitumor Therapy
pp. 4410-4421(12)
Authors: Lian, ChengXiang; Guo, Yeye; Zhang, Jianglin; Chen, Xiang; Peng, Cong

Favourites:
ADD

Dual Roles of Pin1 in Cancer Development and Progression
pp. 4422-4425(4)
Authors: Han, Hyeong-jun; Choi, Bu Y.; Surh, Young-Joon

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content